Literature DB >> 15539161

The effect of copper deficiency on rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity.

N Y Yount1, D J McNamara, A A Al-Othman, K Y Lei.   

Abstract

The effect of copper deficiency on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, the key enzyme regulating cholesterol biosynthesis, was investigated in the rat. Male weanling rats were fed semipurified diets containing adequate, marginal, or deficient levels of copper for 6 weeks. Two separate studies were conducted; in the first study, animals were fasted 12 hours prior to analysis and in the second study, animals were fed diets ad libitum. Plasma lipid levels, hepatic cholesterol concentrations, and 3-hydroxy-3-methylglutaryl coenzyme A reductase specific activity, total and active, were determined. Consistent with previous findings, plasma total cholesterol and triglyceride levels were significantly elevated in copper-deficient rats. Copper deficiency resulted in a significant decrease in hepatic total cholesterol levels. Total and active levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase in fed animals were elevated twofold with copper deficiency, with the active form of the enzyme constituting approximately 30% of total activity. 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in copper-deficient fasted rats was twofold higher than for the fasted adequate animal; however, fasting did result in a 10-fold reduction in hepatic reductase specific activity. These data support the hypothesis that copper deficiency results in a hypercholesterolemic state in the rat associated with increased hepatic cholesterol synthesis.

Entities:  

Year:  1990        PMID: 15539161     DOI: 10.1016/0955-2863(90)90094-2

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  5 in total

1.  Low Hepatic Tissue Copper in Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Michael Mendoza; Shelley Caltharp; Ming Song; Lindsay Collin; Juna V Konomi; Craig J McClain; Miriam B Vos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-07       Impact factor: 2.839

2.  The effect of dietary copper on rat plasma apolipoprotein B, E plasma levels, and apolipoprotein gene expression in liver and intestine.

Authors:  A Mazur; F Nassir; E Gueux; P Cardot; J Bellanger; M Lamand; Y Rayssiguier
Journal:  Biol Trace Elem Res       Date:  1992-08       Impact factor: 3.738

3.  Alterations of lipid metabolism in Wilson disease.

Authors:  Jessica Seessle; Annina Gohdes; Daniel Nils Gotthardt; Jan Pfeiffenberger; Nicola Eckert; Wolfgang Stremmel; Ulrike Reuner; Karl Heinz Weiss
Journal:  Lipids Health Dis       Date:  2011-05-19       Impact factor: 3.876

4.  Links between copper and cholesterol in Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Sharon La Fontaine
Journal:  Front Physiol       Date:  2013-05-16       Impact factor: 4.566

5.  Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.

Authors:  María L Couce; Isidro Vitoria; Luís Aldámiz-Echevarría; Ana Fernández-Marmiesse; Iria Roca; Marta Llarena; Paula Sánchez-Pintos; Rosaura Leis; Alvaro Hermida
Journal:  Orphanet J Rare Dis       Date:  2016-09-09       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.